Tiffany Mecham, an OCRA Advocate Leader, is using her platform as a contestant in the upcoming Mrs. Idaho pageant to raise awareness of ovarian cancer. In a segment with Sophia … Continued
OCRA’s Advocates are off to a running start this year with help from our largest Advocate Leader cohort in program history, at 125 participants representing 39 states and 111 congressional districts. … Continued
Registration is now closed. Survivors, caregivers and supporters are invited to join OCRA and use their voices to advocate for federal funding of ovarian cancer research and education programs. Attend … Continued
Ovarian Cancer Research Alliance is pleased to welcome our 2024 cohort of Advocate Leaders, the biggest ever for our organization with a total of 125 participants. This year’s group, which … Continued
Welcome to OCRA’s Advocate’s Corner, a new monthly series to keep you updated on how our Advocate Leaders and policy team are working on behalf of the ovarian and gynecologic … Continued
The voices of OCRA’s advocates were amplified by recent television coverage of this year’s Fall Advocacy Day, during which more than 70 people from 30 states met with over 120 Congressional offices … Continued
A sea of teal washed over the Capitol when more than 70 advocates from 30 states met with over 120 Congressional offices to push for legislative initiatives, including Medicare coverage … Continued
OCRA’s Fall Advocacy Day returns to Capitol Hill and October 23rd – 24th. The deadline to register has passed. Join us as we advocate for federal programs and research that … Continued
OCRA has joined 71 other organizations in signing on to a letter calling for the U.S. Senate to incorporate critical reforms into the Prescription Drug User Fee Act (PDUFA) reauthorization … Continued
Urge your Senators TODAY to co-sponsor a $50 million budget — a $5 million funding increase over current levels — for the federal Ovarian Cancer Research Program! This April, we … Continued
We need your help today to ensure that a critical ovarian cancer research program is adequately funded. The congressional appropriations process for the 2023 fiscal year is well underway and the ovarian … Continued
Update: On 3/11/22, President Biden SIGNED the FY2022 spending bill into law, implementing key ovarian cancer program increases. This represents a major win for the ovarian cancer community, and we … Continued
Get email updates about research news, action alerts, and ways to join the fight.
